Adrian D. Hobson

779 total citations
25 papers, 385 citations indexed

About

Adrian D. Hobson is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Adrian D. Hobson has authored 25 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Adrian D. Hobson's work include Monoclonal and Polyclonal Antibodies Research (13 papers), HER2/EGFR in Cancer Research (10 papers) and Synthetic Organic Chemistry Methods (3 papers). Adrian D. Hobson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), HER2/EGFR in Cancer Research (10 papers) and Synthetic Organic Chemistry Methods (3 papers). Adrian D. Hobson collaborates with scholars based in United States, Germany and China. Adrian D. Hobson's co-authors include Charles M. Marson, Roger Wrigglesworth, Andrew J. Walker, Harry Adams, M.A. Argiriadi, Christopher M. Harris, Varinder K. Aggarwal, Richard S. Grainger, Kristine E. Frank and Jonathan S. George and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Adrian D. Hobson

24 papers receiving 362 citations

Peers

Adrian D. Hobson
Mingsong Shi China
Guy Fournet France
Michael Soth United States
Cyrille Kuhn United States
Kelly M. George United States
Manfred Schudok Germany
Andrew Burchat United States
Jonathan L. Doty United States
Atsuo Baba Japan
Michael Mokotoff United States
Mingsong Shi China
Adrian D. Hobson
Citations per year, relative to Adrian D. Hobson Adrian D. Hobson (= 1×) peers Mingsong Shi

Countries citing papers authored by Adrian D. Hobson

Since Specialization
Citations

This map shows the geographic impact of Adrian D. Hobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian D. Hobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian D. Hobson more than expected).

Fields of papers citing papers by Adrian D. Hobson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian D. Hobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian D. Hobson. The network helps show where Adrian D. Hobson may publish in the future.

Co-authorship network of co-authors of Adrian D. Hobson

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian D. Hobson. A scholar is included among the top collaborators of Adrian D. Hobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian D. Hobson. Adrian D. Hobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moliner, Fabio De, Kathy Sarris, Zhi Wang, et al.. (2025). Fluorogenic Platform for Real-Time Imaging of Subcellular Payload Release in Antibody–Drug Conjugates. Journal of the American Chemical Society. 147(9). 7578–7587. 6 indexed citations
2.
Santora, Ling C., Adrian D. Hobson, Lu Wang, & Kan Xing Wu. (2024). Impact of drug-linker on method selection for analytical characterization and purification of antibody–drug conjugates. Analytical Methods. 16(22). 3492–3503.
3.
Hobson, Adrian D., Haizhong Zhu, Wei Qiu, Russell A. Judge, & Kenton L. Longenecker. (2024). Minimising the payload solvent exposed hydrophobic surface area optimises the antibody-drug conjugate properties. RSC Medicinal Chemistry. 15(3). 832–838. 4 indexed citations
4.
Hobson, Adrian D.. (2024). The medicinal chemistry evolution of antibody–drug conjugates. RSC Medicinal Chemistry. 15(3). 809–831. 7 indexed citations
5.
Hobson, Adrian D.. (2023). The Medicinal Chemistry of Glucocorticoid Receptor Modulators. Springer briefs in molecular science. 5 indexed citations
6.
Hobson, Adrian D.. (2023). Antibody drug conjugates beyond cytotoxic payloads. Progress in medicinal chemistry. 62. 1–59. 7 indexed citations
7.
Wang, Lu, et al.. (2023). Impact of dipeptide on ADC physicochemical properties and efficacy identifies Ala–Ala as the optimal dipeptide. RSC Medicinal Chemistry. 15(1). 355–365. 6 indexed citations
8.
Hobson, Adrian D., Jianwen Xu, Seán McCarthy, et al.. (2023). Linker substitution influences succinimide ring hydrolysis equilibrium impacting the stability of attachment to antibody–drug conjugates. RSC Medicinal Chemistry. 15(2). 612–622. 4 indexed citations
9.
McPherson, Michael J., Wendy Waegell, Shaughn H. Bryant, et al.. (2021). POS0365 ANTI-TNF GLUCOCORTICOID RECEPTOR MODULATOR ANTIBODY DRUG CONJUGATE FOR THE TREATMENT OF AUTOIMMUNE DISEASES. Annals of the Rheumatic Diseases. 80. 412–413. 7 indexed citations
10.
Vasudevan, Anil, M.A. Argiriadi, Aleksandra Baranczak, et al.. (2019). Covalent binders in drug discovery. Progress in medicinal chemistry. 58. 1–62. 31 indexed citations
11.
Hobson, Adrian D., Jeremy Packer, Christopher Butler, & Dirk A. Bornemeier. (2017). Registration of Antibody Drug Conjugates. 5. 2 indexed citations
12.
Goedken, Eric R., M.A. Argiriadi, David Banach, et al.. (2015). Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol. Journal of Biological Chemistry. 290(8). 4573–4589. 73 indexed citations
13.
Turnbull, Mark M., et al.. (2015). Lewis Acid Catalyzed Cyclizations of Epoxidized Baylis–Hillman Products: A Straightforward Synthesis of Octahydrobenzo[e]azulenes. European Journal of Organic Chemistry. 2015(24). 5453–5463. 1 indexed citations
14.
Hobson, Adrian D., Christopher M. Harris, Elizabeth L. van der Kam, et al.. (2015). Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders. Journal of Medicinal Chemistry. 58(23). 9154–9170. 38 indexed citations
15.
16.
17.
18.
Marson, Charles M., et al.. (1991). Stereocontrolled syntheses of hydroxylated tricyclic systems by a new annulation of 2-cyclohexen-1-one. Tetrahedron. 47(29). 5491–5506. 23 indexed citations
19.
Marson, Charles M., et al.. (1990). Convergent, stereocontrolled routes to hydroxylated tricyclic systems: a new annulation of 2-cyclohexen-1-one. Journal of the Chemical Society Chemical Communications. 1516–1516. 16 indexed citations
20.
Burr, Aaron & Adrian D. Hobson. (1969). The crystal and molecular structure of 2-bromo-N-salicylideneaniline. Acta Crystallographica Section B. 25(12). 2662–2663. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingsong Shi Breakdown of academic impact, for papers by Guy Fournet Breakdown of academic impact, for papers by Michael Soth Breakdown of academic impact, for papers by Cyrille Kuhn Breakdown of academic impact, for papers by Kelly M. George Breakdown of academic impact, for papers by Manfred Schudok Breakdown of academic impact, for papers by Andrew Burchat Breakdown of academic impact, for papers by Jonathan L. Doty Breakdown of academic impact, for papers by Atsuo Baba Breakdown of academic impact, for papers by Michael Mokotoff
Rankless by CCL
2026